Filing Details

Accession Number:
0001127602-19-018293
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-13 15:54:11
Reporting Period:
2019-05-10
Accepted Time:
2019-05-13 15:54:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224661 David Phillips 3471 River Hills Drive
Cincinnati OH 45244
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-10 981 $0.00 0 No 4 J Direct
Common Stock Acquisiton 2019-05-10 981 $0.00 5,981 No 4 J Direct
Common Stock Disposition 2019-05-10 245 $0.00 5,736 No 5 G Direct
Common Stock Acquisiton 2019-05-10 245 $0.00 33,371 No 5 G Indirect By David C. Phillips Family Trust
Common Stock Acquisiton 2019-05-13 5,000 $11.40 38,371 No 4 P Indirect By David C. Phillips Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 J Direct
No 5 G Direct
No 5 G Indirect By David C. Phillips Family Trust
No 4 P Indirect By David C. Phillips Family Trust
Footnotes
  1. Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Direct Common Stock holdings totaled 5,981.
  2. This transaction was a gift of securities to the David C. Phillips Family Trust.